This inventor holds 1 USPTO granted patent and 9 published patent applications and 3 EPO patents. Top assignee: Dsm IP Assets B.v.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Elisabeth Stoecklin: Innovator in Vitamin D3 Research
Introduction
Elisabeth Stoecklin is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of medical research, particularly in the treatment of conditions associated with increased eotaxin levels. Her innovative approach utilizes 25-hydroxyvitamin D3, also known as calcifediol, to address these health issues.
Latest Patents
Elisabeth holds a patent for her work titled "Methods for treating/preventing conditions associated with an increased level of eotaxin in a human with 25-hydroxyvitamin D3." This patent highlights her research on the therapeutic potential of vitamin D3 in conjunction with 25-hydroxyvitamin D3 for treating specific medical conditions. She has 1 patent to her name, showcasing her commitment to advancing medical science.
Career Highlights
Elisabeth Stoecklin is associated with Dsm IP Assets B.V., where she continues to explore innovative solutions in her field. Her work has garnered attention for its potential impact on health and wellness, particularly in relation to eotaxin and vitamin D3.
Collaborations
Elisabeth collaborates with esteemed colleagues such as Stephanie Krammer-Lukas and Joseph Schwager. These partnerships enhance her research efforts and contribute to the advancement of knowledge in her area of expertise.
Conclusion
Elisabeth Stoecklin's contributions to medical research through her innovative patent on vitamin D3 demonstrate her dedication to improving health outcomes. Her work continues to inspire advancements in the treatment of conditions related to eotaxin.